Actively Recruiting
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
Led by University Hospital, Rouen · Updated on 2025-09-10
184
Participants Needed
3
Research Sites
138 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
For patients diagnosed with non-small cell lung cancer (NSCLC), lung resection surgery remains the gold standard for curative treatment. This scheduled operation is associated with significant morbidity, particularly in individuals with impaired cardio-respiratory function. Therefore, patient optimization is paramount. The process begins prior to surgery with preoperative rehabilitation, commonly referred to as "prehabilitation," serving as the foundation for various Enhanced Recovery After Surgery programs. The training methods employed in these programs bear similarity to rehabilitation programs designed for patients with chronic obstructive pulmonary disease (COPD). Postoperatively, patients undergoing thoracic surgery partake in daily physiotherapy sessions, aiming to optimize the postoperative period, minimize the respiratory impact of surgery, and reduce the length of hospital stay. However, this treatment is not currently standardized and primarily involves early mobilization, including walking, and respiratory physiotherapy. Our focus is on the intensity and methods of this postoperative rehabilitation. There is limited literature on effective early rehabilitation in the immediate postoperative period, and existing studies suggest no adverse events associated with postoperative training. Therefore, our objective is to assess whether combining endurance training with standard physiotherapy (walking and respiratory physiotherapy) enhances the functional capacity of individuals undergoing lung surgery.
CONDITIONS
Official Title
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients requiring surgery for diagnosed or undergoing diagnosis of lung cancer.
- Patients in need of major lung resection through a minimally invasive approach.
- Patients capable of performing the chair rise test.
You will not qualify if you...
- Contraindications to cyclo-ergometry, such as deep vein thrombosis in a lower limb.
- Patients with one or both lower limbs amputated.
- Rheumatological pathology, trauma, or previous surgery in the lower limb, pelvis, or spine causing limited joint movement or strict immobilization.
- Severe dermatological conditions preventing prolonged sitting on a bicycle.
- Glasgow score less than 15.
- Patients who have not undergone pulmonary resection by minimally invasive surgery.
- Patients hospitalized outside the thoracic surgery department before the first post-operative visit with the physiotherapist on Day 0.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Valenciennes, Hospital
Valenciennes, Hauts-de-France, France, 59322
Actively Recruiting
2
CAEN, university Hospital
Caen, Normandy, France, 14033
Actively Recruiting
3
Rouen, University Hospital
Rouen, Normandy, France, 76 031
Actively Recruiting
Research Team
J
Jean-Marc BASTE, PhD
CONTACT
F
Fairuz BOUJIBAR, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here